Daniel J. Burdick

Ser ¹²⁹² Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations

Zejuan Sheng, Shuo Zhang, Daisy Bustos et al. · Science Translational Medicine · 2012 · 375 citations

Medicine, Cell Biology, Pharmacology +10

Generation of an LFA-1 Antagonist by the Transfer of the ICAM-1 Immunoregulatory Epitope to a Small Molecule

Thomas R. Gadek, Daniel J. Burdick, Robert S. McDowell et al. · Science · 2002 · 170 citations

Life Sciences, Immunology, Pharmacology +17

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 164 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cyclic RGD peptide analogs as antiplatelet antithrombotics

Peter L. Barker, Sherron Bullens, Stuart Bunting et al. · Journal of Medicinal Chemistry · 1992 · 160 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Andrew McGarry, Shane Rosanbalm, Mika Leinonen et al. · The Lancet Neurology · 2023 · 129 citations

Life Sciences, Neurology, Neuroscience +9